{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:30:04Z","timestamp":1790400604938,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T00:00:00Z","timestamp":1636416000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["RP30005"],"award-info":[{"award-number":["RP30005"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.yebeh.2021.108368","type":"journal-article","created":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T19:43:53Z","timestamp":1636659833000},"page":"108368","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Antiseizure medications and oral contraceptives: Impact of enzyme inducers on pregnancy outcomes and costs"],"prefix":"10.1016","volume":"125","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7765-6399","authenticated-orcid":false,"given":"Seri","family":"Anderson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"Mauskopf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4719-3703","authenticated-orcid":false,"given":"Sandra E.","family":"Talbird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annesha","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenakshi","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.yebeh.2021.108368_b0005","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.contraception.2008.02.002","article-title":"Reproductive history, sexual behavior and use of contraception in women with epilepsy","volume":"77","author":"Davis","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.yebeh.2021.108368_b0010","doi-asserted-by":"crossref","unstructured":"Miller S, Wherry LR, Foster DG. What happens after an abortion denial? A review of results from the Turnaway study. Presented at the AEA Papers and Proceedings. 2020. p. 226-30.","DOI":"10.1257\/pandp.20201107"},{"issue":"Suppl_2","key":"10.1016\/j.yebeh.2021.108368_b0015","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.3949\/ccjm.71.Suppl_2.S25","article-title":"Risks and management of pregnancy in women with epilepsy","volume":"71","author":"Yerby","year":"2004","journal-title":"Cleve Clin J Med"},{"issue":"2","key":"10.1016\/j.yebeh.2021.108368_b0020","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.seizure.2013.10.003","article-title":"Impact of planning of pregnancy in women with epilepsy on seizure control during pregnancy and on maternal and neonatal outcomes","volume":"23","author":"Abe","year":"2014","journal-title":"Seizure"},{"issue":"5","key":"10.1016\/j.yebeh.2021.108368_b0025","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.contraception.2011.01.021","article-title":"Contraceptive failure in the United States","volume":"83","author":"Trussell","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.yebeh.2021.108368_b0030","first-page":"1","article-title":"Current contraceptive status among women aged 15\u201349: United States, 2017\u20132019","volume":"388","author":"Daniels","year":"2020","journal-title":"NCHS Data Brief"},{"issue":"1","key":"10.1016\/j.yebeh.2021.108368_b0035","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.contraception.2017.10.003","article-title":"Contraceptive method use in the United States: trends and characteristics between 2008, 2012 and 2014","volume":"97","author":"Kavanaugh","year":"2018","journal-title":"Contraception"},{"key":"10.1016\/j.yebeh.2021.108368_b0040","unstructured":"United Nations Department of Economic and Social Affairs Population Division. World contraceptive use 2019 (POP\/DB\/CP\/Rev2019). 2019. https:\/\/www.un.org\/en\/development\/desa\/population\/publications\/dataset\/contraception\/wcu2019.asp\/. [accessed 2 April 2021]."},{"issue":"9837","key":"10.1016\/j.yebeh.2021.108368_b0045","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0140-6736(12)60609-6","article-title":"Contraception and health","volume":"380","author":"Cleland","year":"2012","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.yebeh.2021.108368_b0050","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.yebeh.2009.02.023","article-title":"Female issues in epilepsy: a critical review","volume":"15","author":"Luef","year":"2009","journal-title":"Epilepsy Behav"},{"issue":"5801","key":"10.1016\/j.yebeh.2021.108368_b0055","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1136\/bmj.1.5801.686-c","article-title":"Unplanned pregnancy in an epileptic","volume":"1","author":"Kenyon","year":"1972","journal-title":"Br Med J"},{"issue":"8","key":"10.1016\/j.yebeh.2021.108368_b0060","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1212\/WNL.0000000000003637","article-title":"Predictors of unintended pregnancy in women with epilepsy","volume":"88","author":"Herzog","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2021.108368_b0065","doi-asserted-by":"crossref","unstructured":"Sarayani A, Brown JD, Goodin AJ, Squires P, Pham P, Cicali B, et al. A pharmacoepidemiologic approach to evaluate real-world effectiveness of hormonal contraceptives in the presence of drug-drug interactions. Epidemiology. 2021:268-76. doi: 10.1097\/EDE.0000000000001302.","DOI":"10.1097\/EDE.0000000000001302"},{"issue":"37","key":"10.1016\/j.yebeh.2021.108368_b0070","doi-asserted-by":"crossref","DOI":"10.3310\/hta11370","article-title":"A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial","volume":"11","author":"Marson","year":"2007","journal-title":"Health Technol Assess"},{"issue":"10282","key":"10.1016\/j.yebeh.2021.108368_b0075","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(21)00246-4","article-title":"The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial","volume":"397","author":"Marson","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.yebeh.2021.108368_b0080","unstructured":"Centers for Disease Control and Prevention National Center for Health Statistics. Health, United States, 2017: With special feature on mortality, Table 80. Hyattsville, MD: 2018. https:\/\/www.cdc.gov\/nchs\/data\/hus\/2017\/080.pdf. [accessed 18 December 2020]."},{"key":"10.1016\/j.yebeh.2021.108368_b0085","unstructured":"US Census Bureau Population Division. Annual estimates of the resident population for selected age groups by sex for the United States: April 1, 2010, to July 1, 2019 (NC-EST2019-AGESEX). 2020. https:\/\/www2.census.gov\/programs-surveys\/popest\/tables\/2010-2019\/national\/asrh\/nc-est2019-agesex.xlsx. [accessed 18 December 2020]."},{"issue":"5","key":"10.1016\/j.yebeh.2021.108368_b0090","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.contraception.2013.04.001","article-title":"The creeping pearl: why has the rate of contraceptive failure increased in clinical trials of combined hormonal contraceptive pills?","volume":"88","author":"Trussell","year":"2013","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.yebeh.2021.108368_b0095","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.bpobgyn.2008.11.008","article-title":"Understanding contraceptive failure","volume":"23","author":"Trussell","year":"2009","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"7","key":"10.1016\/j.yebeh.2021.108368_b0100","first-page":"1","article-title":"Estimated pregnancy rates and rates of pregnancy outcomes for the United States, 1990\u20132008","volume":"60","author":"Ventura","year":"2012","journal-title":"Natl Vital Stat Rep"},{"issue":"3","key":"10.1016\/j.yebeh.2021.108368_b0105","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/AOG.0b013e3181d0c328","article-title":"Trends in the diagnosis and treatment of ectopic pregnancy in the United States","volume":"115","author":"Hoover","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.yebeh.2021.108368_b0110","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1056\/NEJMsa1506575","article-title":"Declines in unintended pregnancy in the United States, 2008\u20132011","volume":"374","author":"Finer","year":"2016","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.yebeh.2021.108368_b0115","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1363\/3809006","article-title":"Disparities in rates of unintended pregnancy in the United States, 1994 and 2001","volume":"38","author":"Finer","year":"2006","journal-title":"Perspect Sex Reprod Health"},{"key":"10.1016\/j.yebeh.2021.108368_b0120","first-page":"1","article-title":"Intended and unintended births in the United States: 1982\u20132010","volume":"55","author":"Mosher","year":"2012","journal-title":"Natl Health Stat Report"},{"key":"10.1016\/j.yebeh.2021.108368_b0125","unstructured":"Kost KM-Z, I; Kochhar, S. Pregnancy desires and pregnancies at the state level: estimates for 2014. New York: Guttmacher Institute 2018. https:\/\/www.guttmacher.org\/report\/pregnancy-desires-and-pregnancies-state-level-estimates-2014."},{"issue":"2","key":"10.1016\/j.yebeh.2021.108368_b0130","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.contraception.2012.07.016","article-title":"Burden of unintended pregnancy in the United States: potential savings with increased use of long-Acting reversible contraception","volume":"87","author":"Trussell","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.yebeh.2021.108368_b0135","unstructured":"US Bureau of Labor Statistics. Consumer Price Index, medical care component. 2020. https:\/\/www.nhes.nh.gov\/elmi\/statistics\/documents\/cpiuscomp.pdf. [accessed 9 April 2021]."},{"issue":"1","key":"10.1016\/j.yebeh.2021.108368_b0140","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.contraception.2014.08.011","article-title":"Achieving cost-neutrality with long-acting reversible contraceptive methods","volume":"91","author":"Trussell","year":"2015","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.yebeh.2021.108368_b0145","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.contraception.2006.11.009","article-title":"The cost of unintended pregnancy in the United States","volume":"75","author":"Trussell","year":"2007","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.yebeh.2021.108368_b0150","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.contraception.2013.10.019","article-title":"Cost-effectiveness analysis of levonorgestrel-releasing intrauterine system (LNG-IUS) 13.5 mg in contraception","volume":"89","author":"Trussell","year":"2014","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.yebeh.2021.108368_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajog.2004.09.004","article-title":"Cost-effectiveness and contraceptive effectiveness of the transdermal contraceptive patch","volume":"192","author":"Sonnenberg","year":"2005","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.yebeh.2021.108368_b0160","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/AOG.0000000000000907","article-title":"Cost-effectiveness of immediate compared with delayed postpartum etonogestrel implant insertion","volume":"126","author":"Gariepy","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.yebeh.2021.108368_b0165","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0010-7824(03)00078-7","article-title":"Economic analysis of contraceptives for women","volume":"68","author":"Chiou","year":"2003","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.yebeh.2021.108368_b0170","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.contraception.2012.06.009","article-title":"Extending contraceptive coverage under the Affordable Care Act saves public funds","volume":"87","author":"Burlone","year":"2013","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.yebeh.2021.108368_b0175","doi-asserted-by":"crossref","first-page":"595.e1","DOI":"10.1016\/j.ajog.2018.08.043","article-title":"Medicaid savings from the Contraceptive CHOICE Project: a cost-savings analysis","volume":"219","author":"Madden","year":"2018","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.yebeh.2021.108368_b0180","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.fertnstert.2014.09.032","article-title":"Timing of postpartum intrauterine device placement: a cost-effectiveness analysis","volume":"103","author":"Washington","year":"2015","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.yebeh.2021.108368_b0185","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.contraception.2012.11.011","article-title":"Cost analysis of immediate postabortal IUD insertion compared to planned IUD insertion at the time of abortion follow up","volume":"87","author":"Salcedo","year":"2013","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.yebeh.2021.108368_b0190","first-page":"12","article-title":"Modeled cost differences associated with use of levonorgestrel intrauterine devices","volume":"9","author":"Law","year":"2017","journal-title":"Am J Pharm Benefits"},{"issue":"1","key":"10.1016\/j.yebeh.2021.108368_b0195","article-title":"Development of a pharmacoeconomic registry: an example using hormonal contraceptives. Health","volume":"11","author":"White","year":"2021","journal-title":"Econ Rev"},{"issue":"2","key":"10.1016\/j.yebeh.2021.108368_b0200","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1586\/ecp.10.3","article-title":"Clinical pharmacokinetic interactions between antiepileptic drugs and hormonal contraceptives","volume":"3","author":"Reddy","year":"2010","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.yebeh.2021.108368_b0205","unstructured":"Micromedex. Cost of copper IUD (PARAGARD). 4 February 2021. https:\/\/www.micromedexsolutions.com."},{"key":"10.1016\/j.yebeh.2021.108368_b0210","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.yebeh.2018.05.019","article-title":"Patient characteristics and treatment patterns in patients with newly diagnosed epilepsy: a US database analysis","volume":"85","author":"Faught","year":"2018","journal-title":"Epilepsy Behav"},{"issue":"5","key":"10.1016\/j.yebeh.2021.108368_b0215","doi-asserted-by":"crossref","first-page":"E213","DOI":"10.1097\/AOG.0000000000003827","article-title":"Gynecologic management of adolescents and young women with seizure disorders: ACOG Committee Opinion, Number 806","volume":"135","author":"Hewitt","year":"2020","journal-title":"Obstet Gynecol"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505021006296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505021006296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T03:48:48Z","timestamp":1778816928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505021006296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":43,"alternative-id":["S1525505021006296"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2021.108368","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiseizure medications and oral contraceptives: Impact of enzyme inducers on pregnancy outcomes and costs","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2021.108368","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108368"}}